Do Options Traders Know Something About Qiagen Stock We Don't?

Impact · against what's priced in

The article provides no material catalyst for QGEN. The slight increase in analyst EPS estimates is marginal and consistent with the growth the market already assumes, while high options volatility is a non-fundamental signal.

QGEN+0.00

Already priced in

The price assumes

1. The 1-2% constant-exchange-rate sales growth and at least $2.43 adjusted EPS for 2026.

The increase in the Zacks Consensus Estimate from 62 to 63 cents per share is a negligible revision that aligns with the earnings the market already expects for 2026.

What QGEN's price assumes · Sep 2

• equity research
• QGEN
• biomedical
• earnings estimates
• genetics
• implied volatility
• options

Search tags